Inovio Pharmaceuticals
INO
INO
184 hedge funds and large institutions have $196M invested in Inovio Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 67 increasing their positions, 36 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
184
Holders Change
-14
Holders Change %
-7.07%
% of All Funds
3.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
67
Reduced
36
Closed
32
Calls
$2.14M
Puts
$2.82M
Net Calls
-$682K
Net Calls Change
+$923K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$55.7M |
| 2 |
Two Sigma Advisers
New York
|
$5.24M |
| 3 |
Two Sigma Investments
New York
|
$7.92M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$23.1M |
| 5 |
BlackRock
New York
|
$34.5M |
